Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

Ángela Molina-Crespo1,2, Ana Cadete3,4, David Sarrio1,2

  • 1Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPaz, Madrid, Spain.

Abstract

Insights

Targeting Gasdermin B (GSDMB) with nanomedicine offers a new strategy for HER2 breast cancers. This approach reduces tumor growth, metastasis, and therapy resistance by delivering an anti-GSDMB antibody intracellularly.

Area of Science:

  • Oncology
  • Nanomedicine
  • Molecular Biology

Background:

  • Gasdermin B (GSDMB) overexpression is prevalent in HER2 breast cancers, correlating with increased cell migration, therapeutic resistance, and poor prognosis.
  • GSDMB's role in promoting aggressive tumor behavior necessitates novel therapeutic strategies targeting its intracellular functions.

Purpose of the Study:

  • To develop and evaluate a targeted nanomedicine for intracellular delivery of an anti-GSDMB antibody in HER2 breast cancer.
  • To investigate the efficacy of this nanomedicine in reducing GSDMB-driven tumor cell migration, enhancing anti-HER2 therapy response, and inhibiting tumor growth and metastasis.

Main Methods:

  • Development of hyaluronic acid-based nanocapsules for targeted intracellular delivery of an anti-GSDMB antibody.
  • In vitro and in vivo testing using HER2 breast cancer cell models and orthotopic xenografts.
  • Assessment of GSDMB binding to sulfatides and its impact on cell death pathways.

Main Results:

  • The anti-GSDMB antibody delivered via nanocapsules specifically reduced GSDMB-induced cell migration in vitro.
  • Nanoparticle-delivered antibody enhanced sensitivity to trastuzumab and reduced tumor growth by increasing apoptosis in vivo.
  • Therapy significantly diminished lung metastasis in MDA-MB-231-HER2 cells and was linked to increased GSDMB-sulfatide binding.

Conclusions:

  • This study presents the first evidence of an effective antibody-based nanomedicine targeting an intracellular oncoprotein (GSDMB).
  • Intracellular delivery of anti-GSDMB antibody successfully inhibited key protumor functions, including migration, metastasis, and therapy resistance.
  • This nanomedicine represents a promising new targeted therapeutic strategy for aggressive HER2-positive breast cancers with poor outcomes.

Related Concept Videos

Aggression01:47

Aggression

Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.5K
Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
372
Secondary Motives: Affiliation Motivation and Aggression Motivation01:21

Secondary Motives: Affiliation Motivation and Aggression Motivation

Affiliation motivation is the intrinsic desire to connect with others and belong to a social group, which plays a crucial role in forming and maintaining personal relationships. This type of motivation is essential for psychological well-being, as it provides individuals with a sense of community and support. An example of this is a student who joins a study group in order to feel a sense of connection. People with high affiliation motivation actively seek social approval, take satisfaction in...
669
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K